Financhill
Back

NovaBay Pharmaceuticals Quote, Financials, Valuation and Earnings

The Mysterious VC Firm Behind Nvidia's Secret Weapon

Details Here!
Sell
45

NBY
NovaBay Pharmaceuticals

Last Price:
0.77
Seasonality Move:
-8.12%

7 Day Trial

ALL ACCESS PASS

$ 7

Yours Free! Top SIX AI Dividend Stocks Right Now

NO CREDIT CARD REQUIRED!

NovaBay Pharmaceuticals Price Quote

$0.77
+0.02 (+1.85%)
(Updated: November 6, 2024 at 4:23 AM ET)

NovaBay Pharmaceuticals Key Stats

Sell
45
NovaBay Pharmaceuticals (NBY) is a Sell

Day range:
$0.74 - $0.77
52-week range:
$0.36 - $12.77
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.04
P/B ratio:
0%

Volume:
148.2K
Avg. volume:
805.9K
1-year change:
-93.98%
Market cap:
$3.7M
Revenue:
$14.7M
EPS:
$-48.15

How Much Does NovaBay Pharmaceuticals Make?

Is NovaBay Pharmaceuticals Growing As A Company?

NovaBay Pharmaceuticals Stock Price Performance

What Is NovaBay Pharmaceuticals 52-Week High & Low?

NovaBay Pharmaceuticals Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy NovaBay Pharmaceuticals?

Is NovaBay Pharmaceuticals Cash Flow Positive?

  • What Is NBY Cash Flow From Operations?
    Cash flow from operations (TTM) is -$3.4M
  • What Is NovaBay Pharmaceuticals’s Cash Flow From Financing?
    Cash flow from financing (TTM) is -$1.7M
  • What Is NovaBay Pharmaceuticals’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $1.1M

NovaBay Pharmaceuticals Return On Invested Capital

  • Is Management Doing A Good Job?
    NBY return on invested capital is -224.49%
  • What Is NovaBay Pharmaceuticals Return On Assets?
    ROA measures how assets are converting to revenues and is -113.02%
  • What Is NBY Return On Equity?
    ROE is a measure of profitability and is -288.89%

NovaBay Pharmaceuticals Earnings Date & Stock Price

NovaBay Pharmaceuticals Competitors

NovaBay Pharmaceuticals Dividend Yield

NovaBay Pharmaceuticals Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 20.7%
Revenue: -32.09% -23.93%

Analyst Recommendations

Buy Recommendations: 2
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 7.30
Upside from Last Price: 866.89%

Major Shareholders

  • How many NBY shares are owned by institutional investors?
    540.3K NBY shares are owned by institutional investors
  • How many NBY shares are owned by insiders?
    2.1M NBY shares are owned by insiders